Used in pharmaceutical research as an intermediate for synthesizing bioactive compounds targeting central nervous system disorders. Shows potential in the development of agents affecting neurotransmitter regulation due to structural features related to amine and pyrrolidine moieties. Also explored for its role in creating novel analogs with possible antidepressant or stimulant activity. Not intended for direct therapeutic use without further chemical modification and clinical evaluation.